Efficacy of Omitting H2 Antagonists versus Famotidine in Taxane Hypersensitivity Reactions Prophylaxis: A Randomized, Prospective, Open-Label, Controlled Trial
Chaichana Chantharakhit, Tanarat Ruchakorn, Pathra Theeratrakul, Buraphat Pengnoraphat · 2024
Read Efficacy of Omitting H2 Antagonists versus Famotidine in Taxane Hypersensitivity Reactions Prophylaxis: A Randomized, Prospective, Open-Label, Controlled Trial by Chaichana Chantharakhit, Tanarat Ruchakorn, Pathra Theeratrakul, Buraphat Pengnoraphat (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12008344.txt.
Description
Chaichana Chantharakhit and co-authors run a trial on allergy prevention in chemotherapy in a 2024 paper. Taxane drugs can trigger fast allergic reactions during infusion. Patients get preventive drugs first, often including an acid blocking agent. The trial asked whether dropping that agent changes reaction rates at all.
Patients were split by chance into a group without the agent and one with it. Each group received hundreds of chemotherapy cycles over the trial. Reaction rates were low and nearly identical in both groups. The risk gap between groups was tiny, and the authors report the omission made no clear difference.
Catalog record
| CREATOR | Chaichana Chantharakhit, Tanarat Ruchakorn, Pathra Theeratrakul, Buraphat Pengnoraphat |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 20 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |